Onglyza

Onglyza Tablet is an oral medication prescribed for managing type 2 diabetes mellitus. When combined with proper diet and regular physical activity, it helps regulate blood glucose levels, thereby reducing the risk of serious diabetic complications such as kidney impairment and vision loss.

This medication is typically recommended when lifestyle modifications and other antidiabetic drugs prove inadequate for glycemic control. Your physician may prescribe it as monotherapy or in combination with other diabetes medications. It can be administered regardless of meals.

Dosage is determined by your medical condition and blood glucose readings. Strict adherence to your doctor’s instructions is essential. Continue treatment unless advised otherwise by your healthcare provider. Maintaining the prescribed dietary and exercise regimen is crucial during therapy, as lifestyle factors significantly influence diabetes management.

Common adverse effects may include hypoglycemia, upper respiratory infections, urinary tract infections, headaches, and peripheral edema. Patients should learn to recognize hypoglycemia symptoms (dizziness, sweating, lightheadedness, fainting, dry mouth) and carry glucose tablets or candy for emergency management. Consult your physician if side effects persist or cause concern.

Prior to initiating treatment, disclose any history of renal impairment, cardiovascular conditions, or pancreatic disorders. Pregnant or nursing women should seek medical advice before use. Inform your doctor about all concurrent medications due to potential interactions. Alcohol consumption should be limited as it may increase hypoglycemia risk. Regular monitoring of renal function and blood glucose levels may be required to assess treatment efficacy.